Case Study: New and Emerging Pharmaceutical Manufacturer achieves reliable cold-chain supply and nationwide commercial launch with IntegriChain

New and Emerging Pharmaceutical Manufacturer - Customer Case Study

The New and Emerging Pharmaceutical Manufacturer was preparing to launch its first branded self‑administered cold‑chain specialty product while building the company, and needed a steady, predictable supply chain plus a reliable order‑to‑cash system. To choose the right third‑party logistics (3PL) partner—critical for commercialization and revenue recognition—the customer engaged IntegriChain (via Blue Fin Group) to help define detailed, requirements‑driven criteria and guide the selection.

IntegriChain, through Blue Fin Group, led cross‑functional alignment, built bottom‑up 3PL requirements, and facilitated the RFP with capabilities analysis and financial modeling. The selected 3PL met expectations for call center service, order‑to‑cash performance and data reporting, enabling the product to be licensed and available in all 50 states at launch, providing day‑one commercial support and allowing the manufacturer to transition from a title to a non‑title model as commercial benchmarks were met.